Efficacy, safety and tolerability of rabeprazole in treatment of acid-peptic diseases;Avaliaição da eficácia, segurança e tolerabilidade de rabeprazol no tratamento de doenças ácido-pépticas

Arquivos de Gastroenterologia

Volumn 39, Issue 1, 2002, Pages 60-65

  De Freitas, José Alves ^a,d   Lima, Lúcia Maria Praciano ^b   Ranieri, José Luiz ^b   Olivieri Jr , Cláudio ^b   Fragoso, Hélio José ^b   Chinzon, Décio ^c  

^a Faculdade de Medicina de Catanduva   (Brazil)

^b Gastroenterologista Cd de Sao Paulo   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d FAMECA   (Brazil)

Author keywords

Benzimidazoles; Peptic ulcer; Proton pumps

Indexed keywords

RABEPRAZOLE; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ANTIULCER AGENT; BENZIMIDAZOLE DERIVATIVE; DRUG DERIVATIVE; OMEPRAZOLE;

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DUODENUM ULCER; ENDOSCOPY; EROSIVE GASTRITIS; FEMALE; GASTROESOPHAGEAL REFLUX; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PEPTIC ULCER; REFLUX ESOPHAGITIS; STOMACH ULCER; ULCER HEALING; ADOLESCENT; CLINICAL TRIAL; MULTICENTER STUDY; TREATMENT OUTCOME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; ANTI-ULCER AGENTS; BENZIMIDAZOLES; FEMALE; HUMANS; MALE; OMEPRAZOLE; PEPTIC ULCER; TREATMENT OUTCOME;

EID: 0038408557     PISSN: 00042803     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-28032002000100011     Document Type: Article

References (12)

1. Besancon M, Simon A, Sachs G, Shin JM. Sites of reaction of the gastric H, KATPase with extracytoplasmatic thiol reagents. J Biol Chem 1997;272:22438-46.
2. Chiba N. Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview. Can J Gastroenterol 1997;11 Suppl B:66B-73B.
3. Cloud ML, Olovich K. LY307640 versus placebo in healing erosive, ulcerative reflux esophagitis. Gastroenterology 1995;108 Suppl:73.
4. Dean BD, Siddique RM, Yamashita BD, Bhattacharjya AS, Ofman, JJ. Costeffectiveness of proton-pump inhibitors for maintenance therapy of erosive reflux esophagitis. Am J Health-Syst Pharm 2001;58:1338-46.
5. Dekkers CP, Beker JA, Thjodleifsson B, Gabryelewicz A, Bell NE, Humphries TJ. Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer: a European multicentre study. Aliment Pharmacol Ther 1999;13:179-86.
6. Dekkers CP, Beker JA, Thjodleifsson B, Gabryelewicz A, Bell NE, Humphries TJ. Double-blind, placebo controlled comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. The European Rabeprazole Study Group. Aliment Pharmacol Ther 1999;13:49-57.
7. Humphries TJ, Spera A. Rabeprazole sodium (E3810) once daily is superior to ranitidine 150 mg qid in the healing of erosive or ulcerative gastroesophageal reflux disease. Gastroenterology 1996;110 Suppl:4.
8. Kromer W, Krüger U, Huber R, Hartmann M, Steinijans VW. Differences in pH-dependent activation rates of substituted benzimidazoles and biological in vitro correlates. Pharmacology 1998;56:57-70.
9. Kromer W, Horbach S, Lülmann R. Relative efficacies of gastric proton pump inhibitors: their clinical and pharmacological basis. Pharmacology 1999;59:57-77.
10. Stach WA, Knifton A, Thirlwell D, Cockayne A, Jenkins D, Hawkey CJ, Atherton JC. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration. Am J Gastroenterol 1998;93:1909-13.
11. Thjodleifsson B, Dekkers CPM. Rabeprazol sodium 20 mg once daily is similar to omeprazole 20 mg once daily in the treatment of erosive or ulcerative GERD. Gastroenterology 1997;112 Suppl:A312.
12. Williams MP, Sercombe J, Hamilton MI, Punder RE. A placebo-controlled trial to asses the effects of a 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects. Aliment Pharmacol Ther 1998;12:1079-89.